Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome

Shibo Jiang Lindsley F Kimball Research Institute, New York Blood Center, New York, NY, USA; Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai Medical College and Institute of Medical Microbiology, Fudan University, Shanghai, China; Lindsley F Kimball Research Institute, New York Blood Center, New York, NY, USA; Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai Medical College and Institute of Medical Microbiology, Fudan University, Shanghai, China

Maria Elena Bottazzi Sabin Vaccine Institute, Washington, DC, USA; Texas Children’s Hospital Center for Vaccine Development, Houston, TX, USA; Section of Pediatric Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Departments of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA; National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Sabin Vaccine Institute, Washington, DC, USA; Texas Children’s Hospital Center for Vaccine Development, Houston, TX, USA; Section of Pediatric Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Departments of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA; National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA

Lanying Du Lindsley F Kimball Research Institute, New York Blood Center, New York, NY, USA

Sara Lustigman Lindsley F Kimball Research Institute, New York Blood Center, New York, NY, USA

Chien-Te Kent Tseng Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA

Elena Curti Sabin Vaccine Institute, Washington, DC, USA; Texas Children’s Hospital Center for Vaccine Development, Houston, TX, USA; Section of Pediatric Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Departments of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA; National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Sabin Vaccine Institute, Washington, DC, USA; Texas Children’s Hospital Center for Vaccine Development, Houston, TX, USA; Section of Pediatric Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Departments of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA; National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA

Kathryn Jones Sabin Vaccine Institute, Washington, DC, USA; Texas Children’s Hospital Center for Vaccine Development, Houston, TX, USA; Section of Pediatric Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Departments of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA; National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Sabin Vaccine Institute, Washington, DC, USA; Texas Children’s Hospital Center for Vaccine Development, Houston, TX, USA; Section of Pediatric Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Departments of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA; National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA

Bin Zhan Sabin Vaccine Institute, Washington, DC, USA; Texas Children’s Hospital Center for Vaccine Development, Houston, TX, USA; Section of Pediatric Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Departments of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA; National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Sabin Vaccine Institute, Washington, DC, USA; Texas Children’s Hospital Center for Vaccine Development, Houston, TX, USA; Section of Pediatric Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Departments of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA; National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA

Peter J Hotez Sabin Vaccine Institute, Washington, DC, USA; Texas Children’s Hospital Center for Vaccine Development, Houston, TX, USA; Section of Pediatric Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Departments of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA; National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Sabin Vaccine Institute, Washington, DC, USA. [email protected]

show all

Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome

Articles from other publishers (89)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome

Citations (101)

Read on this site (12)

Articles from other publishers (89)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date